{
    "Trade/Device Name(s)": [
        "EUROIMMUN Anti-West Nile Virus ELISA (IgM)"
    ],
    "Submitter Information": "EUROIMMUN US Inc.",
    "510(k) Number": "K153308",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040854"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NPO"
    ],
    "Summary Letter Date": "July 8, 2016",
    "Summary Letter Received Date": "July 12, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3940"
    ],
    "Regulation Name(s)": [
        "West Nile Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgM antibodies to West Nile virus"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Li-heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "96-well microtiter plates",
        "ELISA reader"
    ],
    "Method(s)/Technology(ies)": [
        "ELISA"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "Substrate",
        "Wash solution",
        "Conjugate",
        "Antibody",
        "Plate",
        "Stop solution"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN Anti-West Nile Virus ELISA (IgM) qualitative assay to detect IgM antibodies to West Nile virus in human serum and plasma",
    "Indications for Use Summary": "Qualitative detection of IgM antibodies to West Nile virus in serum and plasma as an aid in the presumptive laboratory diagnosis of West Nile virus infection in patients with symptoms consistent with meningitis/encephalitis; positive results require confirmation by PRNT or CDC guidelines.",
    "fda_folder": "Microbiology"
}